EUVIMEDEUVIMED entdecken
Crossref

Xian-Lian-Jie-Du Decoction suppresses colorectal cancer liver metastasis by inhibiting Plaur/Hbegf/EGFR-mediated actin cytoskeleton remodeling

Qinchang Zhang, Zeanbang Shi, Jingyang Qian, Xuechen Geng, Yuquan Tao, Dan Dong, Hewen Shi, Dong Zhang, Yang Sun, Haibo Cheng

Phytomedicine · 2026

DOI: 10.1016/j.phymed.2026.158482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Qinchang Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing, 210023, China; The First Clinical…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Colorectal Neoplasms, Liver Neoplasms, Actin Cytoskeleton. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colorectal cancer liver metastasis (CRLM) remains a major clinical challenge. Xian-Lian-Jie-Du Decoction (XLJDD) has shown anti-tumor activity against colorectal cancer, but its mechanism in CRLM remains unclear. PURPOSE: To clarify the anti-metastatic mechanism of XLJDD and identify its Plaur-targeting active constituents in CRLM. STUDY DESIGN: An integrated in vivo, in vitro, transcriptomic, proteomic, and single-cell mechanistic study. METHODS: A CRLM mouse model was established by intrasplenic injection of CT26 cells. Transcriptomic and proteomic analyses were integrated to identify candidate targets. Single-cell RNA sequencing (scRNA-seq) was used to characterize tumor microenvironment changes. Wound-healing, Transwell, phalloidin staining, and an in vivo Plaur-overexpression rescue model were used for functional validation. XLJDD granules and XLJDD-derived compounds in biological samples were profiled by UPLC-MS/MS, and their binding to Plaur was examined by molecular docking, surface plasmon resonance (SPR), and microscale thermophoresis (MST). Hepatic exposure of cyclogalegenin was further quantified by targeted UHPLC-MRM-MS/MS. RESULTS: XLJDD reduced hepatic metastatic burden in metastatic liver tissues. Integrated transcriptomic and proteomic analyses identified the Plaur/Hbegf axis as a candidate target of XLJDD. Mechanistically, Plaur promoted Mmp9-associated Hbegf release, whereas XLJDD suppressed EGFR/ERK signaling and reduced the expression of cytoskeleton-related effectors, including Fscn1 and Cdc42ep1. scRNA-seq revealed that XLJDD reduced a Plaur-high Car6+ malignant subpopulation, increased an Ifit1+ interferon-reactive state, and weakened Spp1-Cd44 signaling between malignant cells and Thbs1+ tumor-associated macrophages. In vivo, Plaur overexpression weakened the anti-metastatic effect of XLJDD. Cyclogalegenin was identified as a tissue-available constituent of XLJDD that directly binds Plaur and suppresses Plaur expression in CT26 cells. Targeted quantification confirmed the presence of cyclogalegenin in liver metastatic tissues after oral XLJDD administration. CONCLUSION: XLJDD suppresses CRLM by targeting Plaur, restraining cytoskeleton remodeling, and remodeling the metastatic tumor microenvironment. Cyclogalegenin may contribute to this activity as a direct Plaur-binding constituent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalColorectal NeoplasmsLiver NeoplasmsActin CytoskeletonAntineoplastic Agents, PhytogenicAnimalsMiceErbB ReceptorsCell Line, TumorIntercellular Signaling Peptides and ProteinsHumansMice, Inbred BALB CTumor MicroenvironmentProteomicsMaleSignal TransductionMembrane GlycoproteinsMicrofilament Proteins

Stichwörter der Autor:innen

Actin cytoskeletonColorectal cancer liver metastasisPlaurSingle-cell RNA sequencingTumor microenvironmentXian-Lian-Jie-Du Decoction

Substanzen

Drugs, Chinese HerbalErbB ReceptorsIntercellular Signaling Peptides and ProteinsEGFR protein, mouseAntineoplastic Agents, Phytogenichepatoma-derived growth factorplastinMembrane GlycoproteinsMicrofilament Proteins

Autor:innen und Institutionen

  • Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing, 210023, China; The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, 210…
  • State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, 210023, China. Electronic address: yangsun@nju.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Q., Shi, Z., Qian, J., Geng, X., Tao, Y., Dong, D., Shi, H., Zhang, D., Sun, Y., & Cheng, H. (2026). Xian-Lian-Jie-Du Decoction suppresses colorectal cancer liver metastasis by inhibiting Plaur/Hbegf/EGFR-mediated actin cytoskeleton remodeling. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158482

Vancouver

Zhang Q, Shi Z, Qian J, Geng X, Tao Y, Dong D, et al. Xian-Lian-Jie-Du Decoction suppresses colorectal cancer liver metastasis by inhibiting Plaur/Hbegf/EGFR-mediated actin cytoskeleton remodeling. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158482

BibTeX
@article{Zhang2026,
  author = {Zhang, Qinchang and Shi, Zeanbang and Qian, Jingyang and Geng, Xuechen and Tao, Yuquan and Dong, Dan and Shi, Hewen and Zhang, Dong and Sun, Yang and Cheng, Haibo},
  title = {Xian-Lian-Jie-Du Decoction suppresses colorectal cancer liver metastasis by inhibiting Plaur/Hbegf/EGFR-mediated actin cytoskeleton remodeling},
  journal = {Phytomedicine},
  year = {2026},
  doi = {10.1016/j.phymed.2026.158482}
}
Kostenlos starten →